Following extensive research, we have built a set of Personalised Support Services for cancer patients. These services are based on research and guidelines and offer evidence-based approaches to improve quality of life, while strengthening the relationship between the patient and their medical team.

They have been built by analysing thousands of scientific publications from high impact factor journals, as well as guidelines, medical literature, and databases. This allows CareAcross to match every patient’s needs with the most appropriate support.

We offer services among the following: 

• Breast cancer
• Lung cancer
• Bowel cancer
• Prostate cancer
• Other cancer types

CareAcross is a digital health company focusing on cancer. It provides 100% personalised support to people affected by cancer through reliable information, useful tools, psychological support & guidance from experts. Its vision is to facilitate faster, more effective oncology research, and interactions that will improve quality of life of patients and caregivers.

Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

We are a multidisciplinary team of clinicians, technologists, and behavioral experts united to tackle some of the most significant challenges in healthcare.

Drawing on multi-year clinical studies conducted by leading oncologists in the US and France, we have developed the first digital platform for the early detection of diseases. These studies highlight the impact of patient-reported symptoms on survival and quality of life, forming the foundation of our innovative approach.

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.